Breast Cancer Metastasis and Drug Resistance Challenges and Progress /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Ahmad, Aamir (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 2nd ed. 2019.
• Σειρά: Advances in Experimental Medicine and Biology, 1152
• Θέματα: Cancer research.; Drug resistance.; Cancer Research.; Drug Resistance.

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast c...

Πίνακας περιεχομένων:

• Chaper 1: Breast Cancer Statistics: Recent trends
• Chapter 2: Epidemiology of Breast Cancer in Women
• Chapter 3: Health and Racial Disparity in Breast Cancer
• Chapter 4: Breast Cancer: Current perspectives on the disease status
• Chapter 5: Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the Same Coin
• Chapter 6: Breast Cancer Heterogeneity in Primary and Metastatic Disease
• Chapter 7: Bone Metastasis of Breast Cancer
• Chapter 8: Therapeutic Options for Metastatic Breast Cancer
• Chapter 9: Chemotherapy and inflammatory cytokine signalling in cancer cells and the tumour microenvironment
• Chapter 10: Current Updates on Trastuzumab Resistance in HER2 overexpressing Breast Cancers
• Chapter 11: Non-coding RNAs as mediators of tamoxifen resistance in breast cancers
• Chapter 12: TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcome Drug Resistance
• Chapter 13: Current state of platinum complexes for the treatment of advanced and drug-resistant breast cancers
• Chapter 14: Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistance
• Chapter 15: Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and its Partners to Overcome Metastasis and Drug Resistance
• Chapter 16: Epigenetics of Breast Cancer: Clinical Status of Epi-Drugs and Phytochemicals
• Chapter 17: Targeting CSC in a most aggressive subtype of breast cancer TNBC
• Chapter 18: Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability
• Chapter 19: NEDD4 Family of E3 Ubiquitin Ligases in Breast Cancer: Spotlight on SMURFs, WWPs and NEDD4
• Chapter 20. Emerging Novel Therapeutics in Triple-Negative Breast Cancer
• Chapter 21.Breast Cancer: Proteolysis and Migration
• Chapter 22: Current and emerging 3D models to study breast cancer.